CDKN2B and neoplasm: By analyzing p15INK4B in vitro, in vivo, and in human tumor cohorts, we present multiple lines of evidence here demonstrating p15INK4B as a markedly stronger tumor suppressor than p16INK4A via dual inhibition of cell cycle and aerobic glycolysis (Warburg effect)20.